LCGMF
LION COPPER & GOLD CORP.
$0.2000
-4.76%
No data for this timeframe.
Vol
SEC Reports2
Recent Activity
Apr 24, 2026
SEC
Lion Copper & Gold Corp. announced progress on its Yerington Copper Project, including finalizing the Definitive Feasibi
8-K — Impact 4/10
Apr 2, 2026
SEC
Lion Copper & Gold Corp. filed an amended 10-K solely to correct the audit report date, with no changes to financial sta
10-K/A — Impact 5/10
Sep 8, 2025
Insider
Stiles Douglas Avery was granted 300,000 shares
VP Sustainability&Environment
Sep 8, 2025
Insider
Banning John was granted 500,000 shares
Chief Executive Officer
Analyst Ratings
1Strong Buy
3Buy
1Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
8-K
4/10
Lion Copper & Gold Corp. announced progress on its Yerington Copper Project, including finalizing the Definitive Feasibi
Apr 24, 2026
MIXED
10-K/A
5/10
Lion Copper & Gold Corp. filed an amended 10-K solely to correct the audit report date, with no changes to financial sta
Apr 2, 2026
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Sep 8, 2025 | Stiles Douglas | A | $0.00 |
| Sep 8, 2025 | Banning John | A | $0.00 |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
2 unique insiders with 2 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 8, 2025 | Stiles Douglas Avery | VP Sustainability&Environment | AWARD | 300,000 | — | — |
| Sep 8, 2025 | Banning John | Chief Executive Officer | AWARD | 500,000 | — | — |
2 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 1 mixed, 1 neutral. Avg impact: 4.5/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 80% buy across 5 analysts — 1 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jan 1, 2023 | 1 | 3 | 1 | 0 | 0 | 80% | |
| Dec 1, 2022 | 1 | 3 | 1 | 0 | 0 | 80% | |
| Nov 1, 2022 | 1 | 3 | 1 | 0 | 0 | 80% | |
| Oct 1, 2022 | 1 | 3 | 1 | 0 | 0 | 80% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.